Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Lenette L. Lu"'
Autor:
Daniela Neudecker, Nora Fritschi, Thomas Sutter, Lenette L. Lu, Pei Lu, Marc Tebruegge, Begoña Santiago-Garcia, Nicole Ritz
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/41019928c8a0401bab90c4923860640f
Autor:
Leela R.L. Davies, Malisa T. Smith, Deniz Cizmeci, Stephanie Fischinger, Jessica Shih-Lu Lee, Lenette L. Lu, Erik D. Layton, Alison D. Grant, Katherine Fielding, Catherine M. Stein, W. Henry Boom, Thomas R. Hawn, Sarah M. Fortune, Robert S. Wallis, Gavin J. Churchyard, Galit Alter, Chetan Seshadri
Publikováno v:
EBioMedicine, Vol 93, Iss , Pp 104678- (2023)
Summary: Background: The prevalence of tuberculosis among men who work in the gold mines of South Africa is among the highest in the world, but a fraction of miners demonstrate consistently negative results upon tuberculin skin test (TST) and IFN-γ
Externí odkaz:
https://doaj.org/article/0c58ca4c3fba49d19ebee7d80aaf7eba
Autor:
Stephen M. Carpenter, Lenette L. Lu
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Despite over a century of research, Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), continues to kill 1.5 million people annually. Though less than 10% of infected individuals develop active disease, the specific host immu
Externí odkaz:
https://doaj.org/article/7912d217524143a780f782bee10d2f6e
Autor:
Patricia S. Grace, Sepideh Dolatshahi, Lenette L. Lu, Adam Cain, Fabrizio Palmieri, Linda Petrone, Sarah M. Fortune, Tom H. M. Ottenhoff, Douglas A. Lauffenburger, Delia Goletti, Simone A. Joosten, Galit Alter
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
With an estimated 25% of the global population infected with Mycobacterium tuberculosis (Mtb), tuberculosis (TB) remains a leading cause of death by infectious diseases. Humoral immunity following TB treatment is largely uncharacterized, and antibody
Externí odkaz:
https://doaj.org/article/fa7779f79cd742d18b14d6b5209ea8be
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Mycobacterium tuberculosis (Mtb) resides in a quarter of the world's population and is the causative agent for tuberculosis (TB), the most common infectious reason of death in humans today. Although cellular immunity has been firmly established in th
Externí odkaz:
https://doaj.org/article/8f000461cea2412b89a46efc34cb65b7
Autor:
Emily H. Adhikari, Pei Lu, Ye jin Kang, Ann R. McDonald, Jessica E. Pruszynski, Timothy A. Bates, Savannah K. McBride, Mila Trank-Greene, Fikadu G. Tafesse, Lenette L. Lu
Publikováno v:
bioRxiv
Immunization in pregnancy is a critical tool that can be leveraged to protect the infant with an immature immune system but how vaccine-induced antibodies transfer to the placenta and protect the maternal-fetal dyad remains unclear. Here, we compare
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f764ca327591a4055c817a0d9a45a505
https://doi.org/10.1101/2023.05.01.538955
https://doi.org/10.1101/2023.05.01.538955
Autor:
Timothy A. Bates, Pei Lu, Ye jin Kang, Devin Schoen, Micah Thornton, Savannah K. McBride, Chanhee Park, Daehwan Kim, William B. Messer, Marcel E. Curlin, Fikadu G. Tafesse, Lenette L. Lu
Each novel SARS-CoV-2 variant renews concerns about decreased vaccine efficacy caused by evasion of vaccine induced neutralizing antibodies. However, accumulating epidemiological data show that while vaccine prevention of infection varies, protection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43d6731ec24d537a0b7670eb5d287356
https://doi.org/10.1101/2022.08.12.22278726
https://doi.org/10.1101/2022.08.12.22278726
Publikováno v:
Current opinion in biotechnology. 78
The COVID-19 pandemic demonstrated that monoclonal antibodies can be deployed faster than antimicrobials and vaccines. However, the majority of mAbs treat cancer and autoimmune diseases, whereas a minority treat infection. This is in part because tar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86e23b84fc2da45bd49f8cd293d1f761
https://pubmed.ncbi.nlm.nih.gov/36242952
https://pubmed.ncbi.nlm.nih.gov/36242952
Autor:
Kirsten E. Wiens, Anita S. Iyer, Taufiqur R. Bhuiyan, Lenette L. Lu, Deniz Cizmeci, Matthew J. Gorman, Dansu Yuan, Rachel L. Becker, Edward T. Ryan, Stephen B. Calderwood, Regina C. LaRocque, Fahima Chowdhury, Ashraful I. Khan, Myron M. Levine, Wilbur H. Chen, Richelle C. Charles, Andrew S. Azman, Firdausi Qadri, Galit Alter, Jason B. Harris
Vibriocidal antibodies are the best characterized correlate of protection against cholera and are used to gauge immunogenicity in vaccine trials. However, there is no vibriocidal titer threshold associated with absolute protection against infection w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::43cdd90ba760c83572d63142b9e4d64d
https://doi.org/10.1101/2022.06.08.22276167
https://doi.org/10.1101/2022.06.08.22276167
Autor:
Stephen M. Carpenter, Lenette L. Lu
Publikováno v:
Frontiers in immunology. 13
Despite over a century of research,Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), continues to kill 1.5 million people annually. Though less than 10% of infected individuals develop active disease, the specific host immun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70f85fac6b7aff3af93ac85d472497f1
https://pubmed.ncbi.nlm.nih.gov/35371092
https://pubmed.ncbi.nlm.nih.gov/35371092